Top Analytics Companies (2,755)

Investor Backing & Capital Strength: Significant financing includes a $56.1M Series C in 2024 and additional growth-capital funding from CIBC Innovation Banking in March 2026, signaling continued investor confidence and runway. Company communications indicate these funds are directed toward product development, R&D, customer success, and sales.

Product Line Growth: Recent launches and expansions span Renewal Analytics, workers’ compensation capabilities (including a claims-triage solution), and a major expansion of the Group Health analytics platform, alongside an integrated Risk Management Life Cycle solution. This pattern points to broadening coverage across underwriting, renewals, and claims.

Customer Loyalty & Retention: Current materials highlight hundreds of enterprise deployments with very high client retention, paired with ongoing wins and deployments in 2025–26 (e.g., Community Health Options, Evolution Risk Partners, and continued 2026 additions). These signals suggest a sticky and expanding customer base.

Market Expansion: The company has scaled through the 2024 Accolite merger and the 2026 Cartesian acquisition, which broaden capabilities and extend its North American and European footprint. Hiring initiatives in India and emphasis on EMEA growth further indicate a wider geographic reach.

Innovation-Driven Growth: The organization has repositioned from digital transformation toward AI services, with recent moves explicitly adding data, analytics, and enterprise AI capabilities. This shift aligns offerings with higher-growth categories.

Diversified Customer Base: Following the Accolite combination, the firm cites serving hundreds of Fortune 1000 and high-growth clients. This signals access to a broad enterprise demand base.

Profitability: Net income rose to $6.79B in 2025 from $4.38B in 2024. The combined ratio improved materially (e.g., S&P-adjusted 89.7% in 2025 and high-80s in early 2026), indicating stronger underwriting performance.

Investor Backing & Capital Strength: Shareholders’ equity increased from about $22.2B in 2022 to $39.9B at year-end 2025 and exceeded $44B by mid-2026. External ratings actions (AM Best A affirmation in Sept 2025; S&P upgrade to A+ in July 2026) underscore improved capitalization.

Resilient & Sustainable Growth: S&P describes deliberate portfolio reshaping and expects 2–3% annual premium growth during 2026–2028. Management emphasizes disciplined, selective expansion following underwriting improvements, prioritizing durable returns over sheer volume.

Product Line Growth: The portfolio is described as 20+ brands with an ongoing cadence of incubating one or two new brands per year. An employee account also notes several new brands launched after the pandemic.

Market Expansion: A 2024 feature outlines plans to expand health and wellness brands into new markets and grow teams. Coverage also points to expanding pet-brand manufacturing capacity, including a facility opened in 2022 that was expanding again in 2025.

Strong Hiring & Retention: Current careers pages and LinkedIn show multiple active openings across finance, HR, creative, acquisition, and manufacturing. Built In’s 2026 profile highlights active hiring and retention as part of the company’s outlook.

Strong Revenue Growth: Revenue is described as having grown nearly sevenfold year-over-year during a breakout year, indicating rapid topline momentum. This acceleration is repeatedly referenced alongside claims of production deployments across multiple industries.

Investor Backing & Capital Strength: A $22 million Series A in January 2026 from multiple investors is cited, providing fresh capital to scale the engineering model and platform. This financing supports continued headcount, product, and market investments.

Market Expansion: The company opened an Abu Dhabi office and now lists hubs in New York, Denver, London, and Abu Dhabi, signaling expanding geographic reach. Independent coverage highlights early regional demand driving the Gulf expansion.

Investor Backing & Capital Strength: Multiple large financings (e.g., a $65M Series C led by Goldman Sachs Alternatives) alongside additional facilities (such as a $35M Stifel debt facility and a $50M growth-capital commitment) indicate strong access to capital and confidence to scale. These transactions are explicitly framed as funding nationwide platform expansion and operational build-out.

Market Expansion: Deployments are described as spanning hundreds of communities across 26 states, with portfolio-wide rollouts such as Navion’s phased deployment across 47 communities and continued clinic/location openings in targeted markets. Expansion plans emphasize entering new geographies and broadening presence across the senior-care continuum.

Product Line Growth: The offering has broadened from a single workflow product into an integrated platform that includes AI-powered monitoring/fall management (Sage Detect), EHR-integrated tasking and labor tools, and skilled-nursing solutions. Expanded integrations with EHR systems (e.g., Yardi, ALIS, ECP, PointClickCare, August Health) further extend product scope and use cases.

Strong Hiring & Retention: Headcount is reported to have expanded by 32 in 2025, and current listings show multiple open roles across engineering, data, security, operations, and customer success. LinkedIn also shows roughly 85 employees, reinforcing sustained organizational growth.

Product Line Growth: Regulatory and product momentum includes FDA clearance of the eVO2peak Module in December 2025 and a portfolio the company describes as 12 cardiovascular digital biomarkers (8 FDA-cleared, 4 clinically validated). This indicates an expanding set of regulated and validated offerings on its platform.

Strategic Partnerships: Integration into Kardigan following the 2025 acquisition connects the platform to an active cardiovascular drug-development pipeline and clinical programs. SEC disclosures outline Prolaio-related patient and revenue milestones and describe deployment in Kardigan’s trials.

Strong Revenue Growth: The company describes a sustained growth streak culminating in its strongest first half on record in 2026, with ARR growth accelerating sharply versus the prior year. Multiple updates cite consecutive record quarters and increasing enterprise contract values, indicating momentum in top-line performance.

Market Expansion: Enterprise adoption broadened across teams and use cases, with international performance highlighted as improving, particularly in EMEA, and platform activity reaching very large scale. Record customer expansion in 2025 and a large, active global footprint suggest widening market reach.

Innovation-Driven Growth: Increasing adoption of agentic AI products (such as Felix and Felix Agentic) is portrayed as a key driver of new sales, upsells, and larger multi-year enterprise commitments. Product updates through 2025–2026 are tied directly to commercial momentum.

Strong Hiring & Retention: Hiring is ongoing with “Our team is growing” messaging and active openings, alongside multiple estimates indicating roughly 11–12% year-over-year headcount growth into the 100–150+ range. Chicago and Miami offices plus remote roles underscore continued scaling.

Product Line Growth: The portfolio has expanded from CreditNinja into NinjaCard’s spending/savings/credit offerings and EDGE’s B2B underwriting and analytics. Ongoing rollouts such as NinjaCard FlexLine/FlexBanking and EDGE enhancements indicate sustained product development.

Diversified Revenue Streams: Operations now span consumer lending/banking and a B2B analytics arm, creating multiple monetization paths. The mix of CreditNinja/NinjaCard with EDGE adds balance beyond a single‑product lender.

Strong Revenue Growth: Revenue is rising at double-digit rates across recent periods, and management has increased full-year guidance, underscoring continued momentum. Growth is visible in both recent quarters and the prior year, indicating sustained top-line expansion.

Diversified Revenue Streams: Both Diagnostics and Data & Applications are expanding, with data-licensing/Insights activity increasing alongside clinical testing volumes. This mix reduces reliance on a single line of business and supports multiple growth vectors.

Strategic Partnerships: Collaborations with major biopharmaceutical companies and broader rollouts of platforms such as Next signal expanding commercial reach. Announced initiatives like a large whole‑genome dataset and work with firms including Merck reinforce external demand for the platform.

Strong Revenue Growth: Historical disclosures point to outsized growth (e.g., revenue increasing 5x in 2020 and more than tripling in 2021), and one dataset estimates revenue rose from $21M in 2023 to $31.9M in 2024. Together with an expanding customer base, this indicates continued commercial momentum.

Investor Backing & Capital Strength: Funding totals about $114.5M, including a $71M Series C backed by major firms, and the company attributes a new Boston office in 2023 to continued growth. This capital base and facilities expansion suggest ample resources to scale.

Market Expansion: The company reports serving 1,000+ companies and highlights new offices and international expansion, alongside recent senior hires in revenue and engineering to support scaling. These signals point to ongoing expansion in customers, footprint, and organizational capacity.

Strong Revenue Growth: Revenue is rising at a double-digit pace, with FY2025 up about 32% to $1.234B and Q1–Q2 2026 growing roughly 28% and 26% year over year, alongside raised FY2026 guidance implying around 24% growth. Larger-account cohorts also expanded materially, reinforcing the top-line trajectory.

Customer Loyalty & Retention: Dollar-based net revenue retention was approximately 109–110%, indicating existing customers are expanding spend on the platform. Higher-value segments grew quickly as well, including customers generating over $50K in ARR rising in the mid-to-high 30% range year over year.

Market Expansion: International revenue is outpacing overall growth, including 42% growth in FY2025 and mid-30% growth in early 2026. Total customers also surpassed 205,000 globally as enterprise and multi-product adoption broadened.

Strong Revenue Growth: Inc. 5000 recognitions cite 82% and 72% three-year growth, and investor disclosures note meaningful 2025 revenue scale, indicating sustained multi-year expansion. While precise YoY rates aren’t public, repeated list appearances and disclosed scale point to continued momentum.

Investor Backing & Capital Strength: Nordic Capital became the majority owner in 2025 to support the next phase of growth, expansion, and platform investment. Additional financing and stated plans for strategic acquisitions further reinforce access to growth capital.

Market Expansion: Customer and data footprint expanded to 170M+ patient records across 200+ provider/payer organizations, with more than 2.25M value-based lives added in 2024. Management and media describe ambitions for further expansion via M&A and potential moves beyond the U.S.

Strong Revenue Growth: Feedback suggests recurring revenue expanded from crossing $500M ARR in 2023 to “approaching $600M” by May 2024. These company disclosures indicate meaningful momentum in subscription scale.

Product Line Growth: Feedback suggests the portfolio has broadened via acquisitions and new capabilities—including Pearl Street Technologies (grid interconnection), Spatial Business Systems (utility design automation), PDS Energy exchange platforms, and TGS’s A2D well‑log library. Enverus also cites rapid uptake of newer AI products and substantial growth in power and renewables since 2021.

Investor Backing & Capital Strength: Feedback suggests capital support is robust, with Blackstone agreeing in 2025 to acquire Enverus in a transaction reported around $6–6.5 billion. This major third‑party deal signals external validation of scale and resources for the next growth phase.

Strong Revenue Growth: Consolidated revenue has increased across recent years, with additional year-over-year gains extending into early 2026. This pattern indicates ongoing top-line expansion even as quarterly and annual growth rates vary.

Profitability: Operating income reached new highs in 2025 and continued to rise in subsequent quarters. This points to improving operating leverage alongside revenue growth.

Product Line Growth: Businesses such as Morningstar Credit, PitchBook, Retirement, and the Direct Platform are cited as key growth engines, with Credit standing out. This breadth of product contributions supports expansion beyond a single offering.

Resilient & Sustainable Growth: Revenue is increasing year over year while larger-account cohorts and contracted revenue backlog also grow, indicating durable demand even as the pace moderates. Management’s latest outlook points to continued expansion rather than contraction.

Profitability: Margins and non-GAAP earnings improved and GAAP losses narrowed, with guidance raised for operating margin in the near term. This suggests strengthening operating leverage alongside ongoing top-line growth.

Innovation-Driven Growth: New AI-powered capabilities and social intelligence initiatives (including Trellis) are highlighted as growth vectors supporting the move upmarket. These efforts align with rising average contract values and enterprise adoption.

Strong Revenue Growth: Reported 2025 trading revenue rose to $12.2B from $9.7B in 2024, and 2026 featured record quarters such as a $7.3B Q2, indicating material topline expansion. EBITDA was also reported higher in 2025, reinforcing financial momentum.

Strong Market Position & Advantage: The company indicates it executes a substantial portion of daily U.S. equity and retail trading volumes and holds a top rank on Tradeweb for U.S. Treasury flows, underscoring entrenched scale. Leadership in listed options and as an NYSE Designated Market Maker further points to durable competitive advantage.

Market Expansion: New initiatives such as launching a High Touch Equities business in late 2025, opening an Amsterdam office in 2026, and operating across 50+ equity and fixed‑income markets signal active expansion. Ongoing hiring—1,800+ employees, dozens of open roles across regions, and the firm’s largest intern class—suggests continued investment in capacity.

Strong Market Position & Advantage: PSA and sister brands are consistently portrayed as dominant in trading-card grading, with the portfolio spanning leading names across authentication and grading. This positioning is reinforced by consolidation of major competitors and broad category coverage.

Market Expansion: The company has expanded through acquisitions (including Beckett) and scaled its physical footprint with new and international grading locations. Capacity additions and geographic buildouts indicate active scaling of operations.

Investor Backing & Capital Strength: The business secured a sizable financing at a multibillion-dollar valuation and later committed substantial capital to expand PSA’s footprint, technology, and hiring. These actions signal strong access to capital to fund growth initiatives.

Strong Revenue Growth: Revenue appears to be increasing over time, with evidence of substantial growth in 2022 and continued year-over-year expansion into early 2023, even as the pace moderates. Feedback suggests the business is still scaling toward a larger revenue base while transitioning to a mature growth profile.

Profitability: Independent credit commentary highlights improved profitability and a deliberate shift toward a profit-focused operating model. Feedback suggests efficiency gains and margin improvement are becoming central to the company’s stability and growth trajectory.

Innovation-Driven Growth: Ongoing AI platform investment, rising adoption of AI capabilities, and product expansion including acquisitions are cited as current growth engines. Feedback suggests these initiatives are supporting continued operational and market expansion.

Strong Revenue Growth: Revenue and ARR are described as growing at double-digit rates across 2023–2025, with seven consecutive years of revenue growth reported through 2023. Feedback suggests momentum came from both new customer logos and expansion ARR in existing enterprises.

Market Expansion: Geographic and customer reach is expanding, with TrakSYS reportedly deployed in thousands of factories across 140+ countries alongside new logo wins and increased bookings. Feedback suggests ongoing enterprise sales hiring and multi-site deployments are broadening coverage.

Investor Backing & Capital Strength: Capital support was bolstered by a 2023 recapitalization led by BVP Forge explicitly aimed at scaling the platform and accelerating growth. Feedback suggests this backing is enabling continued product and organizational investment.